Ignite Creation Date:
2024-05-05 @ 11:21 AM
Last Modification Date:
2024-10-26 @ 9:02 AM
Study NCT ID:
NCT00000721
Status:
COMPLETED
Last Update Posted:
2021-10-28
First Post:
1999-11-02
Brief Title:
An Escalating Dose Tolerance Trial of BG8962 rCD4 in Patients Who Are HIV Antibody Positive
Sponsor:
Organization:
National Institute of Allergy and Infectious Diseases NIAID